Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies

NCT04838171 is registered in ClinicalTrials.gov with Quell Therapeutics Limited as lead sponsor.

NCT NCT04838171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies
Lead sponsor
Quell Therapeutics Limited
Phase
Observational
Overall status
Recruiting
Start date
March 24, 2021
Completion date
January 31, 2030
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, inflammation, rejection; transplant, liver